Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00488670
Status:
TERMINATED
Last Update Posted:
2011-06-06
First Post:
2007-06-18
Brief Title:
Escitalopram and Depression in Elderly Alzheimers Patients
Sponsor:
University of British Columbia
Organization:
University of British Columbia
Study Overview
Official Title:
An Open-label Study of Escitalopram in the Treatment of Major Depressive Disorder in Elderly Patients With Alzheimers Disease
Status:
TERMINATED
Status Verified Date:
2011-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Dr Rabheru left VCH last year and the study was cancelled according to his research coordinator
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To investigate the effect of Escitalopram in a large and diverse of dementia patients suffering from depression
Detailed Description:
This study will assess the efficacy tolerability and safety of escitalopram in the treatment of Major Depressive Disorder in patients with Alzheimers disease over a 24-week period It will also assess the efficacy and tolerability of escitalopram after 12 weeks of treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None